Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Masked Placebo
DRUG
2 trials
Sponsors
NYU Langone Health
, Kansas City Heart Rhythm Research Foundation
Conditions
Atrial Fibrillation
Herpes Zoster Ophthalmicus
Phase 4
Zoster Eye Disease Study
Completed
NCT03134196
NYU Langone Health
Herpes Zoster Ophthalmicus
Start: 2017-08-23
End: 2024-07-22
Updated: 2025-03-07
Unknown Phase
Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction
Not yet recruiting
NCT05464940
Kansas City Heart Rhythm Research Foundation
Atrial Fibrillation
Start: 2025-09-30
End: 2026-06-30
Target: 100
Updated: 2025-08-28
Related Papers
Time-Varying Effects of Valacyclovir Prophylaxis in the Zoster Eye Disease Study
JAMA Ophthalmology
2026-08-13
Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study: A Randomized Clinical Trial.
2025-04-01
2 citations
Low-Dose Valacyclovir in Herpes Zoster Ophthalmicus: The Zoster Eye Disease Randomized Clinical Trial.
2025-04-01
2 citations
Baseline Participant Characteristics at Enrollment in the Zoster Eye Disease Study.
2024-12-01
3 citations